NCT04212416View on ClinicalTrials.gov

Leflunomide in Treating Patients With Steroid Dependent Chronic Graft Versus Host Disease

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 12, 2020

Primary Completion Date

June 22, 2026

Study Completion Date

June 22, 2026

Conditions
Chronic Graft Versus Host DiseaseSteroid Refractory Graft Versus Host Disease
Interventions
DRUG

Leflunomide

Given PO

Trial Locations (1)

91010

City of Hope Medical Center, Duarte

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER

NCT04212416 - Leflunomide in Treating Patients With Steroid Dependent Chronic Graft Versus Host Disease | Biotech Hunter | Biotech Hunter